FNY Managed Accounts’s MediciNova MNOV Stock Holding History

FNY Managed Accounts’s Portfolio MNOV Stock Details MNOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-9,000	Closed	-$31.9K	–	379
2015 Q4	$31.9K	Sell	9,000 -25,200	-74%	-$80K	0.16%	67
2015 Q3	$96.1K	Buy	+34,200	New	+$117K	0.27%	92
2015 Q2	–	Sell	-17,700	Closed	-$62K	–	542
2015 Q1	$62K	Buy	+17,700	New	+$62.9K	0.05%	127

Other funds holding MNOV

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

HCMT

Highland Capital Management (Texas) Dallas, Texas $39M AUM

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

FNY Managed Accounts's MNOV Position: Q1 2016 in Review

FNY Managed Accounts sold out of MediciNova (MNOV) in Q1 2016, closing a stake of 9,000 shares — an estimated $31.9K sold.

FNY Managed Accounts first reported a position in MNOV in Q1 2015 and held it in 3 quarters. The position peaked at $96.1K in Q3 2015. 40 funds tracked by Wall St. Rank hold MNOV as of Q1 2016.

FNY Managed Accounts reported no remaining MediciNova position as of Q1 2016 after selling out during the quarter.
FNY Managed Accounts sold 9,000 MediciNova shares in Q1 2016, an estimated $31.9K.
FNY Managed Accounts first reported a position in MediciNova in Q1 2015 and held it in 3 quarters.
FNY Managed Accounts's MediciNova position peaked at $96.1K in Q3 2015.
40 funds tracked by Wall St. Rank held MediciNova as of Q1 2016.

Based on FNY Managed Accounts's 13F filing for Q1 2016, filed 31 May 2016.